| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Discovery | 10 | 2013 | 326 | 2.290 |
Why?
|
| Drug Design | 11 | 2013 | 379 | 2.060 |
Why?
|
| Computer-Aided Design | 4 | 2012 | 73 | 1.250 |
Why?
|
| Computational Biology | 9 | 2013 | 1270 | 1.190 |
Why?
|
| User-Computer Interface | 4 | 2013 | 286 | 1.100 |
Why?
|
| Quantitative Structure-Activity Relationship | 7 | 2012 | 30 | 0.900 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2012 | 2062 | 0.830 |
Why?
|
| Proteins | 5 | 2012 | 1953 | 0.810 |
Why?
|
| Models, Molecular | 12 | 2013 | 1740 | 0.720 |
Why?
|
| Lipid Bilayers | 1 | 2018 | 52 | 0.670 |
Why?
|
| Glucuronides | 4 | 2013 | 44 | 0.650 |
Why?
|
| Ligands | 6 | 2012 | 992 | 0.620 |
Why?
|
| Phospholipids | 1 | 2018 | 177 | 0.620 |
Why?
|
| Drug Delivery Systems | 3 | 2012 | 678 | 0.620 |
Why?
|
| Databases, Pharmaceutical | 2 | 2013 | 7 | 0.560 |
Why?
|
| Polypharmacy | 2 | 2013 | 57 | 0.520 |
Why?
|
| Blood Proteins | 3 | 2011 | 292 | 0.520 |
Why?
|
| Small Molecule Libraries | 3 | 2013 | 171 | 0.500 |
Why?
|
| Drug Interactions | 2 | 2013 | 555 | 0.480 |
Why?
|
| Nanoparticles | 1 | 2018 | 556 | 0.470 |
Why?
|
| Thiamine Deficiency | 5 | 1997 | 10 | 0.440 |
Why?
|
| Models, Chemical | 3 | 2013 | 186 | 0.430 |
Why?
|
| Antineoplastic Agents | 12 | 2016 | 14288 | 0.430 |
Why?
|
| Microsomes, Liver | 1 | 2013 | 116 | 0.430 |
Why?
|
| Structure-Activity Relationship | 7 | 2013 | 935 | 0.430 |
Why?
|
| Models, Theoretical | 2 | 2007 | 787 | 0.420 |
Why?
|
| Prescription Drugs | 1 | 2013 | 64 | 0.410 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2011 | 7 | 0.410 |
Why?
|
| Molecular Docking Simulation | 1 | 2012 | 153 | 0.410 |
Why?
|
| Biological Assay | 1 | 2013 | 176 | 0.400 |
Why?
|
| ras Proteins | 1 | 2016 | 771 | 0.400 |
Why?
|
| Serum Response Factor | 3 | 2007 | 49 | 0.390 |
Why?
|
| Potassium Channel Blockers | 1 | 2011 | 110 | 0.390 |
Why?
|
| Phosphoproteins | 3 | 2011 | 1151 | 0.380 |
Why?
|
| Glucuronosyltransferase | 4 | 2012 | 108 | 0.380 |
Why?
|
| Hepatocytes | 1 | 2013 | 346 | 0.380 |
Why?
|
| Protein Binding | 12 | 2012 | 3438 | 0.360 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2013 | 4768 | 0.360 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2011 | 226 | 0.360 |
Why?
|
| RNA | 2 | 2012 | 1010 | 0.340 |
Why?
|
| HIV Protease | 1 | 2008 | 6 | 0.340 |
Why?
|
| Binding Sites | 8 | 2012 | 2170 | 0.320 |
Why?
|
| Wernicke Encephalopathy | 3 | 1997 | 12 | 0.310 |
Why?
|
| High-Throughput Screening Assays | 4 | 2014 | 218 | 0.310 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 81 | 0.310 |
Why?
|
| Protein Conformation | 8 | 2012 | 1258 | 0.310 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 596 | 0.310 |
Why?
|
| Indolizines | 1 | 2007 | 46 | 0.300 |
Why?
|
| Phenanthrenes | 1 | 2007 | 42 | 0.290 |
Why?
|
| Alkaloids | 1 | 2007 | 79 | 0.290 |
Why?
|
| Models, Biological | 5 | 2013 | 3242 | 0.290 |
Why?
|
| Models, Statistical | 2 | 2013 | 1177 | 0.280 |
Why?
|
| Database Management Systems | 1 | 2006 | 63 | 0.280 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 148 | 0.280 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2013 | 566 | 0.280 |
Why?
|
| Computer Simulation | 6 | 2014 | 1531 | 0.260 |
Why?
|
| Crystallography, X-Ray | 4 | 2012 | 634 | 0.260 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 1759 | 0.250 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 51 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 6 | 2011 | 1487 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 2 | 2012 | 2334 | 0.230 |
Why?
|
| Thermodynamics | 2 | 2012 | 196 | 0.200 |
Why?
|
| MicroRNAs | 3 | 2014 | 2955 | 0.200 |
Why?
|
| Phenols | 2 | 2012 | 107 | 0.190 |
Why?
|
| Software | 1 | 2008 | 1325 | 0.190 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 129 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2007 | 2236 | 0.190 |
Why?
|
| Neoplasms | 5 | 2016 | 15179 | 0.180 |
Why?
|
| Protein Subunits | 2 | 2008 | 274 | 0.180 |
Why?
|
| Thalamus | 3 | 1997 | 134 | 0.170 |
Why?
|
| Entropy | 1 | 2018 | 38 | 0.170 |
Why?
|
| Static Electricity | 1 | 2018 | 58 | 0.170 |
Why?
|
| Poisson Distribution | 1 | 2018 | 92 | 0.170 |
Why?
|
| Kinetics | 5 | 2013 | 2041 | 0.160 |
Why?
|
| Muscles | 3 | 2005 | 416 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2013 | 507 | 0.160 |
Why?
|
| Down-Regulation | 4 | 2014 | 2078 | 0.140 |
Why?
|
| Biotransformation | 2 | 2013 | 93 | 0.140 |
Why?
|
| Humans | 29 | 2016 | 262270 | 0.140 |
Why?
|
| Drosophila | 1 | 2001 | 839 | 0.130 |
Why?
|
| Catalysis | 3 | 2013 | 249 | 0.130 |
Why?
|
| Diencephalon | 1 | 1995 | 14 | 0.130 |
Why?
|
| Animals | 24 | 2014 | 59490 | 0.130 |
Why?
|
| Databases, Protein | 2 | 2013 | 101 | 0.120 |
Why?
|
| Flavonols | 2 | 2011 | 7 | 0.120 |
Why?
|
| Dizocilpine Maleate | 1 | 1993 | 21 | 0.120 |
Why?
|
| Alcoholism | 1 | 1997 | 308 | 0.120 |
Why?
|
| Flavonoids | 2 | 2012 | 195 | 0.120 |
Why?
|
| Cysteine | 2 | 2012 | 214 | 0.120 |
Why?
|
| Rhodium | 1 | 2013 | 7 | 0.120 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 51 | 0.110 |
Why?
|
| Oligonucleotides | 1 | 2014 | 227 | 0.110 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2003 | 70 | 0.110 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 153 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 234 | 0.110 |
Why?
|
| Caco-2 Cells | 2 | 2012 | 161 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 83 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 1997 | 624 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 1033 | 0.110 |
Why?
|
| Myoblasts, Cardiac | 1 | 2012 | 12 | 0.110 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2012 | 22 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 232 | 0.110 |
Why?
|
| Molecular Conformation | 1 | 2012 | 171 | 0.110 |
Why?
|
| Amino Acids | 2 | 2004 | 727 | 0.110 |
Why?
|
| Sulfotransferases | 1 | 2012 | 36 | 0.100 |
Why?
|
| Flavones | 1 | 2011 | 15 | 0.100 |
Why?
|
| Algorithms | 3 | 2012 | 3889 | 0.100 |
Why?
|
| Chromones | 1 | 2011 | 120 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2011 | 798 | 0.100 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2011 | 37 | 0.100 |
Why?
|
| Cell Transdifferentiation | 1 | 2012 | 111 | 0.100 |
Why?
|
| Drug Industry | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cyclohexanones | 1 | 2011 | 30 | 0.100 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 3127 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 130 | 0.100 |
Why?
|
| Sulfonamides | 2 | 2011 | 1826 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 290 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 165 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 184 | 0.100 |
Why?
|
| Molecular Structure | 4 | 2012 | 524 | 0.090 |
Why?
|
| Pyridones | 1 | 2013 | 350 | 0.090 |
Why?
|
| Homeodomain Proteins | 3 | 2005 | 1139 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 249 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2007 | 4027 | 0.090 |
Why?
|
| Thiadiazoles | 1 | 2010 | 47 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 102 | 0.090 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 2009 | 13 | 0.090 |
Why?
|
| ATP Synthetase Complexes | 1 | 2009 | 5 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 122 | 0.090 |
Why?
|
| 2-Chloroadenosine | 1 | 2009 | 37 | 0.090 |
Why?
|
| Thiepins | 1 | 2008 | 2 | 0.080 |
Why?
|
| Time Factors | 5 | 2012 | 12984 | 0.080 |
Why?
|
| Genes, ras | 1 | 2012 | 667 | 0.080 |
Why?
|
| Hippocampus | 2 | 1994 | 921 | 0.080 |
Why?
|
| Myocardium | 3 | 2005 | 1295 | 0.080 |
Why?
|
| Thymidine Kinase | 1 | 2009 | 193 | 0.080 |
Why?
|
| Dimerization | 1 | 2008 | 303 | 0.080 |
Why?
|
| Lac Operon | 2 | 2005 | 122 | 0.080 |
Why?
|
| beta-Galactosidase | 2 | 2005 | 210 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 853 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 337 | 0.080 |
Why?
|
| Seizures | 1 | 1993 | 988 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 478 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 948 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1997 | 2073 | 0.080 |
Why?
|
| Protein Isoforms | 3 | 2011 | 836 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2003 | 1265 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 573 | 0.070 |
Why?
|
| Adenosine | 1 | 2009 | 291 | 0.070 |
Why?
|
| Organogenesis | 1 | 2007 | 118 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1083 | 0.070 |
Why?
|
| Skin | 1 | 2012 | 1260 | 0.070 |
Why?
|
| Pyrithiamine | 3 | 1995 | 3 | 0.070 |
Why?
|
| Transgenes | 3 | 2005 | 556 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 3632 | 0.070 |
Why?
|
| Transcription Factors | 5 | 2014 | 5253 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2012 | 1645 | 0.070 |
Why?
|
| Myosins | 1 | 2005 | 95 | 0.070 |
Why?
|
| Mesoderm | 2 | 2005 | 403 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1439 | 0.060 |
Why?
|
| Nucleotides | 1 | 2005 | 163 | 0.060 |
Why?
|
| Research Design | 1 | 2012 | 1562 | 0.060 |
Why?
|
| Liver | 2 | 2011 | 2904 | 0.060 |
Why?
|
| Mice | 11 | 2014 | 34393 | 0.060 |
Why?
|
| Nerve Degeneration | 2 | 1997 | 149 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2005 | 134 | 0.060 |
Why?
|
| Brain | 2 | 1997 | 4104 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2012 | 1681 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 566 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 160 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 394 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 606 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4903 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 1879 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2012 | 3529 | 0.060 |
Why?
|
| Luciferases | 1 | 2005 | 444 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 511 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 8882 | 0.060 |
Why?
|
| Rats | 4 | 1997 | 6107 | 0.060 |
Why?
|
| Heart | 2 | 2007 | 1227 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 435 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 464 | 0.060 |
Why?
|
| Learning | 1 | 2006 | 407 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 1208 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 2280 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 186 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2011 | 1424 | 0.050 |
Why?
|
| Heterozygote | 1 | 2005 | 1016 | 0.050 |
Why?
|
| Exons | 2 | 2005 | 1326 | 0.050 |
Why?
|
| DNA | 2 | 2011 | 2683 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 2915 | 0.050 |
Why?
|
| Pharyngeal Muscles | 1 | 2001 | 36 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 204 | 0.050 |
Why?
|
| Genome | 1 | 2005 | 678 | 0.050 |
Why?
|
| Homeobox Protein Nkx-2.5 | 3 | 2005 | 27 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2014 | 4303 | 0.050 |
Why?
|
| Biomarkers | 1 | 2011 | 5056 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 2935 | 0.040 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 14560 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 619 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 828 | 0.040 |
Why?
|
| Chromatin | 1 | 2005 | 950 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 1485 | 0.040 |
Why?
|
| Mutation | 2 | 2012 | 15173 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2504 | 0.040 |
Why?
|
| Glycolysis | 2 | 2013 | 523 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2005 | 2450 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2014 | 246 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2012 | 11972 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2001 | 581 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2007 | 4043 | 0.040 |
Why?
|
| Mammillary Bodies | 1 | 1997 | 3 | 0.040 |
Why?
|
| Microdialysis | 2 | 1994 | 50 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2008 | 300 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2005 | 2023 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 5071 | 0.040 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 739 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2001 | 1111 | 0.040 |
Why?
|
| Atrophy | 1 | 1997 | 261 | 0.040 |
Why?
|
| Cell Count | 1 | 1997 | 507 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 1997 | 140 | 0.030 |
Why?
|
| Neural Pathways | 1 | 1997 | 297 | 0.030 |
Why?
|
| Nervous System | 1 | 1996 | 165 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2008 | 843 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2005 | 6130 | 0.030 |
Why?
|
| Elongin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2009 | 1865 | 0.030 |
Why?
|
| Histamine | 1 | 1994 | 53 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5339 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2005 | 129 | 0.030 |
Why?
|
| Thiamine | 1 | 1993 | 11 | 0.030 |
Why?
|
| Male | 6 | 2013 | 123351 | 0.030 |
Why?
|
| Cyclization | 1 | 2013 | 21 | 0.030 |
Why?
|
| Extracellular Space | 1 | 1993 | 131 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2003 | 112 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1997 | 648 | 0.030 |
Why?
|
| Solutions | 1 | 2003 | 105 | 0.030 |
Why?
|
| United States | 1 | 2010 | 15571 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2005 | 4126 | 0.030 |
Why?
|
| Phloretin | 1 | 2012 | 5 | 0.030 |
Why?
|
| Apigenin | 1 | 2012 | 12 | 0.030 |
Why?
|
| Kaempferols | 1 | 2012 | 9 | 0.030 |
Why?
|
| Actins | 2 | 2005 | 605 | 0.030 |
Why?
|
| Flavanones | 1 | 2012 | 11 | 0.030 |
Why?
|
| Arylsulfotransferase | 1 | 2012 | 18 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 2013 | 216 | 0.030 |
Why?
|
| Genistein | 1 | 2012 | 73 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 2012 | 126 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 1097 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 277 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1995 | 711 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 176 | 0.020 |
Why?
|
| Lentivirus | 1 | 2012 | 168 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 552 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 305 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 590 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 7217 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 4231 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 321 | 0.020 |
Why?
|
| Biological Availability | 1 | 2011 | 225 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 188 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 391 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 4787 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1995 | 2312 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 591 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2003 | 1001 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 625 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 383 | 0.020 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2010 | 41 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 882 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 1516 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 1063 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 289 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 6062 | 0.020 |
Why?
|
| Acute Disease | 1 | 1995 | 2431 | 0.020 |
Why?
|
| Proteolysis | 1 | 2011 | 368 | 0.020 |
Why?
|
| Halogenation | 1 | 2009 | 14 | 0.020 |
Why?
|
| Poly A | 1 | 2009 | 88 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 374 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 481 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 104 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 11571 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 229 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 1093 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2012 | 666 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 283 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 1153 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2008 | 159 | 0.020 |
Why?
|
| Stem Cells | 2 | 2005 | 1206 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 130 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 6927 | 0.020 |
Why?
|
| Female | 4 | 2013 | 142303 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 1760 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 328 | 0.020 |
Why?
|
| Cattle | 1 | 2009 | 783 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 398 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1027 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 1395 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 1554 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 662 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3189 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 1618 | 0.020 |
Why?
|
| Flight, Animal | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1540 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 5155 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 3022 | 0.020 |
Why?
|
| Tongue | 1 | 2005 | 78 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2005 | 48 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 3042 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 252 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 1487 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 1542 | 0.020 |
Why?
|
| Monosaccharides | 1 | 2004 | 24 | 0.020 |
Why?
|
| Ions | 1 | 2004 | 54 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 446 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 1545 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 138 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 3076 | 0.020 |
Why?
|
| Apoptosis | 2 | 2011 | 7602 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 256 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2004 | 110 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 405 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 695 | 0.010 |
Why?
|
| Vitamins | 1 | 2004 | 156 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3983 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 2633 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 4809 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 4945 | 0.010 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2005 | 289 | 0.010 |
Why?
|
| Heart Atria | 1 | 2005 | 352 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 5378 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 767 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 663 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 425 | 0.010 |
Why?
|
| GATA5 Transcription Factor | 1 | 2001 | 4 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6223 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 1435 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 130 | 0.010 |
Why?
|
| Endoderm | 1 | 2001 | 55 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 693 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3818 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 244 | 0.010 |
Why?
|
| Amides | 1 | 2001 | 123 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2001 | 85 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 674 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2005 | 849 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2001 | 209 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 1557 | 0.010 |
Why?
|
| Stomach | 1 | 2003 | 387 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 10021 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 785 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 613 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7241 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 1557 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 1277 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5598 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 5672 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 1268 | 0.010 |
Why?
|
| Methylhistidines | 1 | 1994 | 10 | 0.010 |
Why?
|
| Histamine Release | 1 | 1994 | 15 | 0.010 |
Why?
|
| Receptors, Glutamate | 1 | 1994 | 19 | 0.010 |
Why?
|
| Gliosis | 1 | 1994 | 41 | 0.010 |
Why?
|
| Pyridines | 1 | 2001 | 1243 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7545 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 3317 | 0.010 |
Why?
|
| Necrosis | 1 | 1994 | 583 | 0.010 |
Why?
|
| Neuroglia | 1 | 1994 | 224 | 0.010 |
Why?
|
| Glutamine | 1 | 1994 | 300 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1994 | 309 | 0.010 |
Why?
|
| Cell Death | 1 | 1994 | 672 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 259 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 33032 | 0.010 |
Why?
|